Related Experiment Video
Updated: Jun 21, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Characterizing drug-induced epidermal necrolysis in a pediatric cohort
Ariel B Brown1, Andrew J Park2, Nnenna G Agim3,4
1Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Insights
Pediatric drug-induced epidermal necrolysis is often caused by antiepileptic drugs (AEDs), which can have a delayed onset. Monitor children on AEDs longer for early signs of this severe skin reaction.
Area of Science:
- Pediatric Dermatology
- Pharmacovigilance
- Toxicology
Background:
- Drug-induced epidermal necrolysis (DIEN) is a severe, life-threatening mucocutaneous reaction.
- Understanding the specific clinical course of DIEN in pediatric populations is crucial for timely diagnosis and management.
Purpose of the Study:
- To characterize the timeline and clinical features of onset, progression, and management of drug-induced epidermal necrolysis in pediatric patients.
- To identify common culprit drugs and specific risk factors associated with DIEN in children.
Main Methods:
- Retrospective identification and analysis of 16 pediatric patients (<18 years) with confirmed DIEN.
- Review of patient records to determine culprit drug exposure, onset, progression, and management strategies.
Main Results:
- Antiepileptic drugs (AEDs) were the most frequent culprit drugs (75%), followed by antibiotics (25%).
- AEDs were associated with a delayed onset of DIEN and symptom precipitation by dose escalations.
- Typical onset window for AED-induced DIEN may be longer than previously established.
Conclusions:
- Antiepileptic drugs pose a significant risk for drug-induced epidermal necrolysis in pediatric patients.
- Healthcare providers should consider prolonged monitoring for prodromal symptoms in children prescribed AEDs, especially those with dose escalations.
- Further research into pediatric DIEN is warranted to refine diagnostic and management guidelines.
Abstract:
This study aims to characterize the timeline and clinical features of onset, progression, and management of drug-induced epidermal necrolysis in pediatric patients. Sixteen pediatric patients were retrospectively identified and selected if under age 18 years at admission with one identified culprit drug exposure. Culprit drugs were antiepileptics (12/16, 75%) and antibiotics (4/16, 25%). Notably, anti-epileptic drugs (AED) had delayed onset and reported dose escalations that precipitated symptom onset; thus, patients prescribed AED with or without planned dose escalations should be monitored for prodromal symptoms longer than the typical onset window.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Factors Affecting Drug Response: Overview

